Detalhe da pesquisa
1.
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Blood
; 137(2): 185-189, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259596
2.
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.
Blood
; 131(21): 2357-2366, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483101
3.
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
J Immunol
; 201(7): 1967-1974, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104242
4.
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Blood
; 129(11): 1469-1479, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049639
5.
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.
Blood
; 126(19): 2213-9, 2015 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337493
6.
Clinically indicated ibrutinib dose interruptions and reductions do not compromise long-term outcomes in CLL.
Blood
; 133(22): 2452-2455, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917955
7.
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.
Lancet Oncol
; 16(2): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25555420
8.
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
N Engl J Med
; 367(1): 11-9, 2012 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22762314
9.
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica
; 100(12): 1571-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430171
10.
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
Am J Hematol
; 95(11): E310-E313, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808680
11.
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.
Clin Cancer Res
; 29(18): 3612-3621, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227160
12.
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Blood Adv
; 6(6): 1732-1740, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157769
13.
Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia.
Am J Hematol
; 86(10): 835-40, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21812019
14.
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model.
J Clin Oncol
; 39(6): 576-585, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026937
15.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Leuk Lymphoma
; 62(8): 1816-1827, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653216
16.
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
Leuk Lymphoma
; 61(10): 2375-2382, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508208
17.
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica
; 94(9): 1266-73, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734418
18.
Myoblast replication is reduced in the IUGR fetus despite maintained proliferative capacity in vitro.
J Endocrinol
; 232(3): 475-491, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28053000
19.
Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.
Leukemia
; 31(6): 1340-1347, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28074063
20.
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.
JAMA Dermatol
; 152(6): 698-701, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982511